Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Study topic
No spam. Unsubscribe anytime.
National Academies outlines clinical guidance review for Red Hill exposures; will not assign liability
Summary
The National Academies study team said it will review scientific evidence and community input to recommend clinical follow‑up for people exposed to the Nov. 2021 JP‑5 release at Red Hill, but it will not assign fault, conduct new toxicology experiments, or recommend remediation or who should pay for care.
The National Academies has framed a focused, evidence‑review project to recommend clinical follow‑up for people exposed during the November 2021 JP‑5 release at the Red Hill Bulk Fuel Storage Facility, the committee’s study director said.
"We're a nongovernmental organization that advises the nation on issues related to science, engineering, and medicine," Liz Boyle, senior program officer and study director, told the Fuel Tank Advisory Committee. She said the committee will weigh the strength of the scientific evidence, review existing clinical guidance and exposure assessments, and engage affected community members through listening sessions and liaisons.
Boyle emphasized limits written into the committee’s statement of task: the report will not determine liability or fault for individual health outcomes, will not recommend environmental cleanup measures, and will not decide who should pay medical bills. "Those things are out of scope," she said, adding that the committee also will not conduct original clinical or toxicological experiments.
Instead, Boyle said the National Academies will identify evidence gaps and may recommend primary research where needed. The study, sponsored by the Department of Defense and Department of Veterans Affairs, plans peer review in October 2025 and a public release in March 2026.
Committee members asked whether the report could lead to practical changes in care. Boyle noted precedent in which National Academies reviews informed Department of Veterans Affairs presumptive conditions after Agent Orange research, and said similar clinical recommendations to guide screening or surveillance are possible depending on the weight of evidence.
The committee is collecting public input by email and through scheduled listening sessions, Boyle said, and has launched community liaisons to help reach exposed and dispersed populations.
The National Academies’ role as an independent reviewer, its timeline for peer review, and the study’s limits were the principal takeaways from the presentation, according to FTAC members. Next steps include additional public listening sessions and data‑gathering events announced by the committee.
